By 
Ebola can now be cured. Yes, the researchers have revealed the Ebola virus is now curable. The recent researchers are now a step closer to be able to cure this fatal hemorrhagic fever.
Clinical trials conducted in Congo revealed that there are two novel drugs which are being experimented. Reportedly, these new drugs show ninety percent survival rates.
šØ šØ šØ Two of the four #Ebola drugs being tested in #DRC, have been shown to be more effective. They are the ones that will be used with future patients š https://t.co/Jcq97oP55t pic.twitter.com/H96wcwG2CI
— World Health Organization (WHO) (@WHO) August 12, 2019
Ebola: The two drugs-
Ebola is now curable after trials of drugs in DRC say, scientists.
- REGN-EB3 is a brand-new antibody cocktail. It is developed by REGN.O or Regeneron.
- mAb114 is an effective monoclonal antibody.
The Democratic Republic of Congo (DRC) has announced mAb114 will be accessible to all the infected people. The two drugs combined are a ray of hope for the ongoing DRC outbreak.
The U.S. National Institute of Allergy & Infectious Diseases (NIAID) has revealed that these drugs have a significantly better effect on the patients. The DRC outbreak is reported as the second-largest outbreak of Ebola. Furthermore, according to the trial, about four kinds of potential treatments are conducted for this unfortunate epidemic.
BBC News – #Ebola drugs trials in #Congo show ā90% survival rateā in breakthrough trial https://t.co/ckKuiYnt9f
— Humanity First UK/Int'l (@humanityfirstuk) August 13, 2019
These drugs have gifted significantly higher survival rates in Ebola cases. The two other treatments that are being researched on include
- ZMapp: It is brought by Mapp Biopharmaceutical.
- Remdesivir: It is brought by (GILD.O) or Gilead Sciences.
Anthony Fauci who is a researcher of this trial shared these drugs will soon be released.
Statistics reveal-
The new drugs have gifted us significantly higher survival rates in Ebola cases.
The statistical data of the trial reveals-
- Forty-nine percent of the patients on Zmapp did not survive.
- Fifty-three percent of patients on Remdesivir did not survive.
- Only twenty-nine percent of patients on REGN-EB3 died.
- While thirty-four percent of patients on mAb114 died.
The director-general of the Congoās Institut National de Recherche BiomĆ©dicale in DRC, Jean-Jacques Muyembe co-led this trial. He shared that Ebola is now curable. This new success will save plenty of lives around the globe every day.
Anthony Fauci who is the director at NIAID shared these results are extremely pleasant news. In fact, humanity is now ready to fight against no longer fatal Ebola.
